Volume | 284,298 |
|
|||||
News | - | ||||||
Day High | 0.14 | Low High |
|||||
Day Low | 0.13118 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Elite Pharmaceuticals Inc (QB) | ELTP | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.136235 | 0.13118 | 0.14 | 0.14 | 0.1369 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
61 | 284,298 | $ 0.137039 | $ 38,960 | - | 0.0269 - 0.17 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:58:49 | 1,000 | $ 0.14 | USD |
Elite Pharmaceuticals Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
141.95M | 1.01B | 705.48M | 34.16M | 3.56M | 0.00 | 40.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Elite Pharmaceuticals (QB) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELTP Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1376 | 0.145 | 0.126 | 0.1332205 | 729,438 | 0.0024 | 1.74% |
1 Month | 0.117795 | 0.17 | 0.1015 | 0.1447094 | 1,595,063 | 0.02221 | 18.85% |
3 Months | 0.071 | 0.17 | 0.071 | 0.1281936 | 1,211,476 | 0.069 | 97.18% |
6 Months | 0.032 | 0.17 | 0.0301 | 0.0971618 | 1,217,295 | 0.108 | 337.5% |
1 Year | 0.03335 | 0.17 | 0.0269 | 0.0836578 | 775,026 | 0.10665 | 319.79% |
3 Years | 0.0542 | 0.17 | 0.023 | 0.0606684 | 768,141 | 0.0858 | 158.3% |
5 Years | 0.0805 | 0.17 | 0.023 | 0.0683459 | 787,039 | 0.0595 | 73.91% |
Elite Pharmaceuticals (QB) Description
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. |